Pimasertib Completed Phase 2 Trials for Ovarian Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01936363Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer